Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Evaluation of the Synergy of Ceftazidime-Avibactam in combination with Meropenem, Amikacin, Aztreonam, Colistin and Fosfomycin Against Well Characterized Multi-Drug Resistant K. pneumoniae and P. aeruginosa.

Mikhail S, Singh NB, Kebriaei R, Rice SA, Stamper KC, Castanheira M, Rybak MJ.

Antimicrob Agents Chemother. 2019 Jun 10. pii: AAC.00779-19. doi: 10.1128/AAC.00779-19. [Epub ahead of print]

PMID:
31182535
2.

Daptomycin Dose-Ranging Evaluation with Single-Dose versus Multidose Ceftriaxone Combinations against Streptococcus mitis/oralis in an Ex Vivo Simulated Endocarditis Vegetation Model.

Kebriaei R, Rice SA, Stamper KC, Seepersaud R, Garcia-de-la-Maria C, Mishra NN, Miro JM, Arias CA, Tran TT, Sullam PM, Bayer AS, Rybak MJ.

Antimicrob Agents Chemother. 2019 May 24;63(6). pii: e00386-19. doi: 10.1128/AAC.00386-19. Print 2019 Jun.

PMID:
30962347
3.

Dalbavancin Alone and in Combination with Ceftaroline against Four Different Phenotypes of Staphylococcus aureus in a Simulated Pharmacodynamic/Pharmacokinetic Model.

Kebriaei R, Rice SA, Stamper KC, Rybak MJ.

Antimicrob Agents Chemother. 2019 Mar 27;63(4). pii: e01743-18. doi: 10.1128/AAC.01743-18. Print 2019 Apr.

PMID:
30670436
4.

Evaluation of dalbavancin alone and in combination with β-lactam antibiotics against resistant phenotypes of Staphylococcus aureus.

Xhemali X, Smith JR, Kebriaei R, Rice SA, Stamper KC, Compton M, Singh NB, Jahanbakhsh S, Rybak MJ.

J Antimicrob Chemother. 2019 Jan 1;74(1):82-86. doi: 10.1093/jac/dky376.

PMID:
30260409
5.

Combination of Vancomycin and Cefazolin Lipid Nanoparticles for Overcoming Antibiotic Resistance of MRSA.

Bhise K, Sau S, Kebriaei R, Rice SA, Stamper KC, Alsaab HO, Rybak MJ, Iyer AK.

Materials (Basel). 2018 Jul 20;11(7). pii: E1245. doi: 10.3390/ma11071245.

6.

Influence of Inoculum Effect on the Efficacy of Daptomycin Monotherapy and in Combination with β-Lactams against Daptomycin-Susceptible Enterococcus faecium Harboring LiaSR Substitutions.

Kebriaei R, Rice SA, Singh KV, Stamper KC, Dinh AQ, Rios R, Diaz L, Murray BE, Munita JM, Tran TT, Arias CA, Rybak MJ.

Antimicrob Agents Chemother. 2018 Jul 27;62(8). pii: e00315-18. doi: 10.1128/AAC.00315-18. Print 2018 Aug.

7.

Combination of Tedizolid and Daptomycin against Methicillin-Resistant Staphylococcus aureus in an In Vitro Model of Simulated Endocardial Vegetations.

Smith JR, Yim J, Rice S, Stamper K, Kebriaei R, Rybak MJ.

Antimicrob Agents Chemother. 2018 Apr 26;62(5). pii: e00101-18. doi: 10.1128/AAC.00101-18. Print 2018 May.

8.

Erratum. DDB1-Mediated CRY1 Degradation Promotes FOXO1-Driven Gluconeogenesis in Liver. Diabetes 2017;66:2571-2582.

Tong X, Zhang D, Charney N, Jin E, VanDommelon K, Stamper K, Gupta N, Saldate J, Yin L.

Diabetes. 2017 Dec;66(12):3144. doi: 10.2337/db17-er12e. Epub 2017 Oct 9. No abstract available.

9.

DDB1-Mediated CRY1 Degradation Promotes FOXO1-Driven Gluconeogenesis in Liver.

Tong X, Zhang D, Charney N, Jin E, VanDommelen K, Stamper K, Gupta N, Saldate J, Yin L.

Diabetes. 2017 Oct;66(10):2571-2582. doi: 10.2337/db16-1600. Epub 2017 Aug 8. Erratum in: Diabetes. 2017 Dec;66(12 ):3144.

10.

Lipogenic transcription factor ChREBP mediates fructose-induced metabolic adaptations to prevent hepatotoxicity.

Zhang D, Tong X, VanDommelen K, Gupta N, Stamper K, Brady GF, Meng Z, Lin J, Rui L, Omary MB, Yin L.

J Clin Invest. 2017 Jun 30;127(7):2855-2867. doi: 10.1172/JCI89934. Epub 2017 Jun 19.

11.

Evaluation of daptomycin combinations with cephalosporins or gentamicin against Streptococcus mitis group strains in an in vitro model of simulated endocardial vegetations (SEVs).

Yim J, Smith JR, Singh NB, Rice S, Stamper K, Garcia de la Maria C, Bayer AS, Mishra NN, Miró JM, Tran TT, Arias CA, Sullam P, Rybak MJ.

J Antimicrob Chemother. 2017 Aug 1;72(8):2290-2296. doi: 10.1093/jac/dkx130.

12.

UK epidemic Escherichia coli strains A-E, with CTX-M-15 beta-lactamase, all belong to the international O25:H4-ST131 clone.

Lau SH, Kaufmann ME, Livermore DM, Woodford N, Willshaw GA, Cheasty T, Stamper K, Reddy S, Cheesbrough J, Bolton FJ, Fox AJ, Upton M.

J Antimicrob Chemother. 2008 Dec;62(6):1241-4. doi: 10.1093/jac/dkn380. Epub 2008 Sep 8.

PMID:
18779256
13.

Supplemental Content

Loading ...
Support Center